Ces radiol. 2010, 64(4):259-265

Imaging of phaeochromocytomas and paragangliomas using 18F-FDG-PET/CTOriginal article

Eva Ferdova1, Jiří Ferda1, Ondřej Hes2, Ondřej Daum2, Tomáš Skalický3, Vladislav Třeška3
1 Klinika zobrazovacích metod LF UK a FN, Plzeň
2 Šiklův patologickoanatomický ústav LF UK a FN, Plzeň
3 Chirurgická klinika LF UK a FN, Plzeň

Aim: To evaluate the experience with 18F-FDG-PET/CT in benign and malignant variants of phaeochromocytoma and paragaglioma.

Material and methods: 12 patients underwent 18F-FDG-PET/CT during five years. Phaeochromocytoma or paragaglioma was confirmed in all of them.

Results: Non-metastatic phaeochromocytoma was found in 7 cases, one metastatic respectively. 3 cases of malignant paraganglioblastoma with metastases were found and one paraganglioblastoma in combination with medullary carcinoma of the thyroid. In all tumors, the extreme level of 18F-FDG uptake was expressed.

Conclusion: In tumors arising from autonomous ganglia, the high level uptake of 18F-FDG is present obviously, then the 18F-FDG-PET/CT is the valuable method of their detection.

Keywords: phaeochromocytoma, paraganglioma, paraganglioblastoma, 18F-FDG-PET/CT
Grants and funding:

Práce byla podpořena výzkumným projektem MSM 0021620819.

Accepted: November 1, 2010; Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ferdova E, Ferda J, Hes O, Daum O, Skalický T, Třeška V. Imaging of phaeochromocytomas and paragangliomas using 18F-FDG-PET/CT. Ces radiol. 2010;64(4):259-265.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 1996; 199(3): 743-750. Go to original source... Go to PubMed...
    2. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993; 186(3): 711-715. Go to original source... Go to PubMed...
    3. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET. Radiology 1999; 212(1): 35-41. Go to original source... Go to PubMed...
    4. Troncone L, Maini CL, De Rosa G, Corsello SM, Rufini V, Mattei O, Bonifazi N. Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine. Eur J Nucl Med 1984; 9(9): 429-432. Go to original source... Go to PubMed...
    5. Sudbrock F, Schmidt M, Simon T, Eschner W, Berthold F, Schicha H. Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2010; 37(7): 1279-1290. Go to original source... Go to PubMed...
    6. Hoegerle S, Ghanem N, Altehoefer C, Schipper J, Brink I, Moser E, Neumann HP. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003; 30(5): 689-694. Go to original source... Go to PubMed...
    7. Win Z, Rahman L, Murrell J, Todd J, Al-Nahhas A. The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma. Eur J Nucl Med Mol Imaging. 2006; 33(4): 506. Go to original source... Go to PubMed...
    8. Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ. Functional imaging of malignant paragangliomas and carcinoid tumours. Eur J Nucl Med 2001; 28(4): 478-482. Go to original source... Go to PubMed...
    9. Macfarlane DJ, Shulkin BL, Murphy K, Wolf GT. FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET. Eur J Nucl Med 1995; 22(11): 1347-1350 Go to original source... Go to PubMed...
    10. Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N, Jacobson AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med 2009; 50(9): 1448-1454. Go to original source... Go to PubMed...
    11. Taïeb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, Niccoli-Sire P, Fakhry N, De Micco C, Cammilleri S, Enjalbert A, Henry JF, Mundler O. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med 2009; 50(5): 711-717. Go to original source... Go to PubMed...
    12. Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Långsjö J, Salmi J, Välimäki M, Någren K, Nuutila P. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 2004; 45(6): 972-979.
    13. Binderup T, Knigge U, Loft A, Mortensen J, Pfeifer A, Federspiel B, Hansen CP, Højgaard L, Kjaer A. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET. J Nucl Med 2010; 51(5): 704-712. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content